Redirecting tumor macrophage activity to fight cancer: Make room for the next era of anti-cancer drugs

Ferdinando Pucci; Lisa M. Coussens

doi:10.1016/j.ccell.2021.09.009

Redirecting tumor macrophage activity to fight cancer: Make room for the next era of anti-cancer drugs

Ferdinando Pucci, Lisa M. Coussens

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Abstract

Functionally significant proteins expressed by tumor macrophages have emerged as promising anti-cancer targets. In this issue of Cancer Cell, Sun et al. identify two FDA-approved agents that together safely reprogram tumor macrophages into potent anti-tumor effectors, demonstrating the power of engaging both immune system arms to fight cancer.

Original language	English (US)
Pages (from-to)	1300-1302
Number of pages	3
Journal	Cancer Cell
Volume	39
Issue number	10
DOIs	https://doi.org/10.1016/j.ccell.2021.09.009
State	Published - Oct 11 2021

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1016/j.ccell.2021.09.009

Cite this

@article{00067c01e1af498cb6ea2ea668f6fa38,

title = "Redirecting tumor macrophage activity to fight cancer: Make room for the next era of anti-cancer drugs",

abstract = "Functionally significant proteins expressed by tumor macrophages have emerged as promising anti-cancer targets. In this issue of Cancer Cell, Sun et al. identify two FDA-approved agents that together safely reprogram tumor macrophages into potent anti-tumor effectors, demonstrating the power of engaging both immune system arms to fight cancer.",

author = "Ferdinando Pucci and Coussens, {Lisa M.}",

note = "Publisher Copyright: {\textcopyright} 2021 Elsevier Inc.",

year = "2021",

month = oct,

day = "11",

doi = "10.1016/j.ccell.2021.09.009",

language = "English (US)",

volume = "39",

pages = "1300--1302",

journal = "Cancer Cell",

issn = "1535-6108",

publisher = "Cell Press",

number = "10",

}

TY - JOUR

T1 - Redirecting tumor macrophage activity to fight cancer

T2 - Make room for the next era of anti-cancer drugs

AU - Pucci, Ferdinando

AU - Coussens, Lisa M.

PY - 2021/10/11

Y1 - 2021/10/11

N2 - Functionally significant proteins expressed by tumor macrophages have emerged as promising anti-cancer targets. In this issue of Cancer Cell, Sun et al. identify two FDA-approved agents that together safely reprogram tumor macrophages into potent anti-tumor effectors, demonstrating the power of engaging both immune system arms to fight cancer.

AB - Functionally significant proteins expressed by tumor macrophages have emerged as promising anti-cancer targets. In this issue of Cancer Cell, Sun et al. identify two FDA-approved agents that together safely reprogram tumor macrophages into potent anti-tumor effectors, demonstrating the power of engaging both immune system arms to fight cancer.

UR - http://www.scopus.com/inward/record.url?scp=85118411706&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85118411706&partnerID=8YFLogxK

U2 - 10.1016/j.ccell.2021.09.009

DO - 10.1016/j.ccell.2021.09.009

M3 - Article

C2 - 34637745

AN - SCOPUS:85118411706

SN - 1535-6108

VL - 39

SP - 1300

EP - 1302

JO - Cancer Cell

JF - Cancer Cell

IS - 10

ER -

Redirecting tumor macrophage activity to fight cancer: Make room for the next era of anti-cancer drugs

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this